NF1 and melanoma: Current evidence suggests that genomic changes in DM are very different to that of conventional melanoma, although the only well‐established defining features are a markedly reduced frequency of activating BRAF mutations and loss‐of‐function mutations in NF1 (Wiesner et al., 2015).